Protalix BioTherapeutics, Inc. ( PLX ) recently completed a private placement of its convertible notes worth $69 million. The offering …read more
Protalix BioTherapeutics, Inc. ( PLX ) recently completed a private placement of its convertible notes worth $69 million. The offering …read more